Abstract Body

Improvements in inflammatory biomarker profiles have been documented in virologically-suppressed patients switching from PI and/or NNRTI to RAL and EVG. Because improvements in chronic inflammation may affect mortality and co-morbid disease development, we evaluated the effects of switch to ABC/DTG/3TC on markers of inflammation and immune activation.

Participants were randomized 1:1 to switch to ABC/DTG/3TC or continue current suppressive (HIV-1 RNA <50 copies/mL) ART for 24 weeks. C-reactive protein (hs-CRP), interleukin-6 (IL-6), D-dimer, soluble vascular cell adhesion molecule (sVCAM), soluble CD14 and CD163 (sCD14, sCD163), and intestinal fatty acid binding protein (I-FABP) were measured as secondary endpoints on cryopreserved specimens using standardized assays. Mean 24-week changes in log-transformed biomarker values were compared between participants switching ABC/DTG/3TC vs continued suppressive ART using analysis of covariance (ANCOVA). No statistical adjustment for multiple comparisons was made.

Participants (274 switched to ABC/DTG/3TC, 277 continued current ART) were 86% male, 28% African American and had median age 45 years, CD4+ T lymphocyte count 610 cells/mm3 and median time on ART 4.4 years. At entry, ART use was 42% PI, 31% NNRTI, 26% RAL or EVG, 77% tenofovir and 23% abacavir.  After 24 weeks, mean changes in hs-CRP, IL-6, D-dimer, sVCAM and sCD163 were similar between participants switching to ABC/DTG/3TC and continuing current ART; however, greater declines in I-FABP and sCD14 were observed among participants switching to ABC/DTG/3TC (p<0.05), some of whom switched from RAL and EVG.

Switch to ABC/DTG/3TC was associated with greater declines in sCD14 and I-FABP levels, even among participants switching from other integrase inhibitors. These changes may suggest reduced microbial translocation and monocyte activation following switch to ABC/DTG/3TC, which could have important implications for morbidity and mortality. Additionally, no worsening of markers associated with cardiovascular disease were observed following switch to ABC/DTG/3TC.